RES-010 for Overweight and Moderately Obese Adults

We are investigating a new medication to see how safe it is and how it affects the body in healthy adults who are overweight or moderately obese. This study aims to gather important information about its potential benefits.

1-2 yearsSafety phase (I)EndocrinologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Pharmaceutical Research Associates Group B.V.
Program Management
Groningen, Netherlands
Sponsor: Resalis Therapeutics S.r.l.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.